Related Experiment Videos
Pulmonary physiology in interstitial lung disease: recent developments in diagnostic and prognostic implications
1Division of Pulmonary and Critical Care Medicine, University of Southern California School of Medicine, Los Angeles 90033, USA.
Current Opinion in Pulmonary Medicine
|September 1, 1996
Summary
Interstitial lung disease (ILD) impairs lung function, showing reduced lung volumes and carbon monoxide diffusion. A new negative expiratory pressure test aids in assessing respiratory mechanics and detecting flow limitation in various lung disorders.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Interstitial lung disease (ILD) is characterized by specific pulmonary function changes, including reduced lung volumes and impaired carbon monoxide diffusion capacity.
- Understanding respiratory mechanics in infiltrative lung disease is crucial for assessing disease severity and progression.
Purpose of the Study:
- To evaluate a novel negative expiratory pressure (NEP) test for assessing respiratory mechanics in patients with lung diseases.
- To determine the utility of NEP-generated expiratory flow-volume curves in detecting flow limitation.
Main Methods:
- A new, simple test involving negative expiratory pressure applied at the mouth during tidal expiration was utilized.
- Expiratory flow-volume curves were generated to assess flow limitation in patients with restrictive and obstructive lung disorders.
Main Results:
- The NEP test effectively detects flow limitation in patients with restrictive and obstructive disorders.
- This method is particularly beneficial for patients who experience difficulties with traditional forced maneuvers due to weakness, incoordination, or coughing.
Conclusions:
- Pulmonary function tests in ILD show characteristic changes like decreased lung volumes and diffusion capacity.
- The negative expiratory pressure test offers a valuable, accessible method for evaluating respiratory mechanics and flow limitation, especially in challenging patient populations.